0001042074-17-000008.txt : 20170630
0001042074-17-000008.hdr.sgml : 20170630
20170630131608
ACCESSION NUMBER: 0001042074-17-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170628
FILED AS OF DATE: 20170630
DATE AS OF CHANGE: 20170630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dickinson Klara
CENTRAL INDEX KEY: 0001339895
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 17941312
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BOULEVARD, SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-06-28
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001339895
Dickinson Klara
7999 GATEWAY BOULEVARD, SUITE 130
NEWARK
CA
94560
0
1
0
0
SVP, Regulatory Affairs & QA
Stock Option (right to buy)
5.5
2017-06-28
4
A
0
200000
0
A
2027-06-27
Common Stock
200000
200000
D
The shares subject to the option shall vest according to the following schedule: 25% of the shares subject to the option shall vest on June 26, 2018, and the remaining of the shares shall vest in equal monthly installments over the next 36 months.
/s/ Klara A. Dickinson-Eason
2017-06-29